![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0835.jpg)
• Patients with residual fluorodeoxyglucose-avid disease after four
cycles of R-CHOP were recommended RT regardless of
randomization
• These patients achieved similarly favorable outcome to those with
a PET CR after R-CHOP with or without RT, suggesting a role for
RT in patients who achieve only a PR to chemotherapy